Remi A. Nout

Leiden University Medical Center — Netherlands

Medicine · Health Sciences

74h-index26.6kcitations561works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Endometrial and Cervical Cancer Treatments(307), Ovarian cancer diagnosis and treatment(116), Cervical Cancer and HPV Research(77), Advanced Radiotherapy Techniques(56), Colorectal and Anal Carcinomas(45)

Publications557 total

Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer − PORTEC-4a an international, randomised, phase 3 trial
Radiotherapy and Oncology·2026Open Access
HYpofractionated, dose-redistributed RAdiotherapy (HYDRA) versus conventional radiotherapy for head and neck cancer: planned interim analysis and dosimetric comparison from the phase I HYDRA trial
Clinical and Translational Radiation Oncology·2026Open Access
Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy
Clinical and Translational Radiation Oncology·2026Open Access
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
The Lancet Oncology·2025· 8 cited
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial
Obstetrical & Gynecological Survey·2025
Clinical factors affecting the therapeutic dose window in cervical cancer brachytherapy: A systematic review and meta-regression
Brachytherapy·2025Open Access
Treatment effect estimation by comparing observed and predicted outcomes: theory and practical illustration in radiotherapy
arXiv (Cornell University)·2025Open Access
IMPT VS. VMAT IN ANAL CANCER RADIOTHERAPY: TRADE OFF BETWEEN ORGAN-SPARING POTENTIAL AND SKIN TOXICITY
International Journal of Particle Therapy·2025Open Access
COST-UTILITY ANALYSIS OF A MOLECULAR-INTEGRATED-PROFILE FOR WOMEN WITH (HIGH)INTERMEDIATE RISK ENDOMETRIAL CANCER - PORTEC-4A AN INTERNATIONAL, MULTICENTRE, RANDOMISED, PHASE 3 TRIAL
International Journal of Gynecological Cancer·2025
TOXICITY, HEALTH-RELATED-QUALITY-OF-LIFE AND SEXUAL-HEALTH FOLLOWING MOLECULAR-BASED ADJUVANT TREATMENT IN THE INTERNATIONAL RANDOMISED PORTEC-4A TRIAL
International Journal of Gynecological Cancer·2025
It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer – Authors' reply
The Lancet Oncology·2025
European training requirements for gynecological oncology: the European Society of Gynaecological Oncology Curriculum
International Journal of Gynecological Cancer·2025· 1 citedOpen Access
Response to letter to editor “Re-evaluating ‘Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy’: The silent cumulative CTVIR deficit”
Radiotherapy and Oncology·2025
European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancer
International Journal of Gynecological Cancer·2025· 2 cited
Integrating automated electromagnetic tracking-based needle reconstruction in the intraoperative high-dose-rate prostate brachytherapy workflow
Physics and Imaging in Radiation Oncology·2025Open Access
Predicting lymphocyte dose and surviving fraction for VMAT and IMPT treatments with a dynamic lymphocyte flow model for locally advanced cervical cancer
Physics in Medicine and Biology·2025Open Access
Advances in Thermotherapy for Breast Cancer:A Systematic Review of Clinical and Technological Developments
TU/e Research Portal·2025
Practical strategies for environmentally sustainable practices in gynecologic oncology
International Journal of Gynecological Cancer·2025· 1 cited
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
The Lancet Oncology·2025· 12 citedOpen Access
Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy
Radiotherapy and Oncology·2025Open Access
page 1 of 28Next →

Frequent Co-authors

Carien L. Creutzberg(34), Tjalling Bosse(30), Vincent T.H.B.M. Smit(23), Hans W. Nijman(18), Ina M. Jürgenliemk‐Schulz(12), Denis Querleu(11), Melanie Powell(11), Jan J. Jobsen(11), Stephanie M. de Boer(11), David N. Church(11), Jonathan A. Ledermann(10), Christine Haie-Méder(10), Hein Putter(10), Ludy Lutgens(10), David Cibula(9), Sigurd Lax(9), Linda Mileshkin(9), Nicoletta Colombo(8), Annerie Slot(8), Richard Pötter(8)